A world-renowned LCN to exist across the United States, Canada and eventually the world, to provide innovative therapies, treatment options, expert care and information to families affected by these diseases.


The Global Leukodystrophy Initiative (GLIA) was founded in 2013 to bring together clinicians, researchers and advocacy groups to focus and improve both clinical care and research.